3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
40
Glioma
17
Brain Neoplasms
14
Astrocytoma
11
Neuroblastoma
10
Gliosarcoma
10
Neoplasms
8
Sarcoma, Ewing
7
Rhabdomyosarcoma
6
Recurrence
5
Oligodendroglioma
5
Sarcoma
4
Medulloblastoma
4
Neoplasm Metastasis
3
Diffuse Intrinsic Pontine Glioma
3
Wilms Tumor
2
Small Cell Lung Carcinoma
2
Pancreatic Neoplasms
2
Osteosarcoma
2
Melanoma
2
Lymphoma, Follicular
2
Hepatoblastoma
2
Central Nervous System Neoplasms
2
Spinal Cord Neoplasms
1
Somatostatinoma
1
Rhabdoid Tumor
1
Refractory Solid Tumors
1
Pyloric Stenosis, Hypertrophic
1
Prostatic Neoplasms
1
Pheochromocytoma
1
Interventions
Magnetic Resonance Spectroscopy
5
lutetium Lu 177 dotatate
4
Specimen Handling
4
Radiosurgery
3
gallium Ga 68 dotatate
2
Ga(III)-DOTATOC
2
Bevacizumab
2
regorafenib
1
pembrolizumab
1
olaparib
1
neratinib
1
capivasertib
1
cabozantinib
1
brigatinib
1
abemaciclib
1
X-Rays
1
Watchful Waiting
1
Tablets
1
Surveys and Questionnaires
1
Sunitinib
1
Radiotherapy, Intensity-Modulated
1
Protons
1
Proton Therapy
1
Photons
1
Observation
1
ONC206
1
Nivolumab
1
Mental Status and Dementia Tests
1
Lysine
1
Ipilimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Meningioma
×
Temozolomide
×
90 days
×
Clear all
No trials found.